Pricing updated 2016-02-06. Prices are subject to change without notice.
Phospholipase D (PLD) is an enzyme which cleaves the head group from phospholipids, producing the second messenger phosphatidic acid. Two mammalian isoforms of PLD, PLD1 and PLD2, have been identified, with multiple splice variants of each. Although the two isoforms share structural and functional features, they are regulated differently and apparently subserve distinct roles. CAY10594 is a potent PLD2 inhibitor, both in vitro (IC50 = 140 nM) and in cells (IC50 = 110 nM).1 It is also effective as a PLD1 inhibitor at higher concentrations (IC50 = 5.1 μM in vitro, 1.0 μM in cells).1 CAY10594 strongly inhibits the invasive migration of breast cancer cells in transwell assays,1 suggesting that PLD might be a useful target in blocking tumor cell invasion.
|Formulation||A crystalline solid|
WARNING - This product is not for human or veterinary use.
|Shipping||Room temperature in continental US; may vary elsewhere|
Download Product Insert 111 Kb PDF
Download Safety Data Sheet (SDS) 25 Kb PDF
View the Cayman Structure Database for chemical structure definitions for many Cayman products
Separate multiple batch numbers with commas
Scott, S.A., Selvy, P.E., Buck, J.R., et al. Design of isoform-
We offer you the deep and diverse knowledge of more than 100 in-house scientists and the expertise that comes from more than three decades of designing and developing the tools to advance biomedical research.
Cayman is know as a partner to scientists worldwide, responding to your needs with services in: